Rothschild Investment LLC’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.6K Buy
1,776
+256
+17% +$5.08K ﹤0.01% 1342
2026
Q1
$29.2K Buy
1,520
+91
+6% +$1.79K ﹤0.01% 1275
2025
Q4
$27.1K Buy
1,429
+889
+165% +$16.5K ﹤0.01% 1222
2025
Q3
$10.1K Sell
540
-44
-8% -$822 ﹤0.01% 1449
2025
Q2
$10.8K Buy
584
+110
+23% +$1.95K ﹤0.01% 1194
2025
Q1
$8.28K Buy
474
+170
+56% +$2.87K ﹤0.01% 1225
2024
Q4
$5.26K Buy
304
+65
+27% +$1.19K ﹤0.01% 1329
2024
Q3
$4.45K Buy
239
+115
+93% +$1.94K ﹤0.01% 1341
2024
Q2
$1.91K Buy
124
+50
+68% +$714 ﹤0.01% 1414
2024
Q1
$1.09K Sell
74
-1,978
-96% -$27.4K ﹤0.01% 1259
2023
Q4
$29.3K Buy
+2,052
New +$29.1K ﹤0.01% 773

Other funds holding SBRA

Rothschild Investment LLC's SBRA Position: Q2 2026 in Review

Rothschild Investment LLC increased its Sabra Healthcare REIT (SBRA) stake by 17% in Q2 2026, buying an estimated $5.08K and bringing the position to 1,776 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

Rothschild Investment LLC first reported a position in SBRA in Q4 2023 and has held it in 11 quarters since. 339 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Rothschild Investment LLC held 1,776 shares of Sabra Healthcare REIT worth $34.6K as of Q2 2026.
  • Rothschild Investment LLC bought 256 Sabra Healthcare REIT shares in Q2 2026, an estimated $5.08K.
  • Sabra Healthcare REIT made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1342 holding.
  • Rothschild Investment LLC first reported a position in Sabra Healthcare REIT in Q4 2023 and has held it in 11 quarters since.
  • 339 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.